CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Probiotix Health PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Probiotix Health PLC
Innovation Centre
Innovation Way, Heslington
YORK, YO10 5DG  United Kingdom Ticker: PBXPBX
Business Summary
ProBiotix Health plc is a life sciences company with a strategic focus on probiotics and the human microbiome addressing various aspects of cardiometabolic health and other lifestyle conditions impacting the quality of life throughout the lifespan. The Company operates in the dietary supplement prevention segment, focusing on healthy aging, cardiometabolic health and probiotics. The Company offers YourBiotixMH for menopause health, post menopause health, cholesterol maintenance, cholesterol health, blood pressure reduction, and for vascular health support. It offers LP LDL, which is a naturally occurring probiotic strain of the bacterial species Lactobacillus plantarum, originally isolated from tomatoes. Its LP LDL has a positive impact on multiple cardiometabolic health biomarkers, including Total cholesterol, LDL and HDL cholesterol, Apolipoprotein B, triglycerides and blood pressure.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8049 Offices and clinics of health practitioners, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board AdamReynolds 63
Chief Executive Officer, Executive Director Steen D.Andersen 61 1/1/2023 1/1/2023
Executive Director Stephen P.O'Hara 1/1/2023
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 4 (As of 12/31/2024)
Outstanding Shares: 158,166,666 (As of 6/30/2025)
Stock Exchange: AQS


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, October 25, 2025